Trials / Conditions / Recurrent Indolent Adult Non-Hodgkin Lymphoma

Recurrent Indolent Adult Non-Hodgkin Lymphoma

6 registered clinical trials studyying Recurrent Indolent Adult Non-Hodgkin Lymphoma.

Status	Trial	Sponsor	Phase
Active Not Recruiting	An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That H NCT04447716	Thomas Jefferson University	Phase 1
Completed	Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patient NCT03019640	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma NCT03147885	Barbara Ann Karmanos Cancer Institute	Phase 1 / Phase 2
Terminated	Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent NCT02928510	Jonsson Comprehensive Cancer Center	—
Completed	Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by NCT00789776	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphoc NCT00764517	OHSU Knight Cancer Institute	Phase 2